11.12.26 -- The Latest CDMO Opportunities And Threats Report

Use a gene expression system that allows you to produce molecules that are 100% free of fucose and demonstrate increased potency, without compromising on titers, growth, stability, or product quality.

Learn how next-generation workflows are being developed to streamline iPSC manufacturing, enhance differentiation strategies, and overcome the hurdles of scalability and consistency.

As the advanced therapy field evolves rapidly, the strategic manufacturing choices developers make can prove just as influential as the therapies in reaching patients faster.

Explore expert-led insights on nucleic acid therapeutic modalities, advanced delivery systems, complex formulation challenges, and real-world case studies shaping drug development.

Focus on quality as industry presenters discuss the importance of strictly adhering to cell collection protocols and examining the real-world effects on patient treatment outcomes.

Strengthen your viral safety strategy by applying science- and risk-based approaches to viral clearance planning, ensuring robust data, regulatory compliance, and patient protection.